Riskpilot← Back to searchSign inGet full accessEPIDEMI AS
ASActiveOrg 998198984Ærfuglveien 53, 4623 Kristiansand SResearch and experimental development on natural sciences and engineering · NACE 7210Est. 20120 employeeswww.epidemi.no
Revenue 2025
NOK 36K
-27% vs 2024
EBITDA margin
-29.1%
-267% vs 2024
Equity ratio
-854.2%
Financial strength
Net profit 2025
NOK -10K
-278% vs 2024
| Revenue | NOK 36K | -27% |
| EBITDA | NOK -10K | -267% |
| Net profit | NOK -10K | -278% |
| Total assets | NOK 10K | +30% |
| Equity | NOK -84K | -14% |
| Employees | 0 | — |
Legal name
EPIDEMI AS
Org number
998198984
Legal form
Aksjeselskap
NACE code
7210 · Research and experimental development on natural sciences and engineering
Founded
23. april 2012
Share capital
NOK 100 000
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Styrets leder alene.
Company purpose
Å drive forskning, analyse, utredning og utvikling, samt rådgivning og undervisning innen smittevern, epidemiologi, folkehelse, helseberedskap, kommunikasjon, programvare og vitenskapelig publisering.
Address
Ærfuglveien 53, 4623 Kristiansand S
Website
www.epidemi.no
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 250 | 1 179 | 374 | 98 | 16 | 35 | 65 | 40 | 47 | 28 | 37 | 59 | 49 | 36 |
| Staff expenses | −172 | −1 029 | −239 | −0 | −0 | −0 | −0 | −2 | −0 | −0 | −0 | −0 | −0 | −0 |
| EBITDA | −70 | −43 | 13 | 8 | −32 | 1 | 18 | −50 | 14 | −7 | −26 | 12 | 6 | −10 |
| Depreciation & amort. | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −4 | −5 | −6 | −0 | −0 | −0 |
| EBIT | −70 | −43 | 13 | 8 | −32 | 1 | 18 | −50 | 10 | −12 | −32 | 12 | 6 | −10 |
| Net financials | 0 | 0 | −3 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | −0 | 0 | −0 | −0 |
| Profit before tax | −70 | −43 | 10 | 8 | −32 | 1 | 18 | −50 | 10 | −12 | −32 | 12 | 6 | −10 |
| Tax | −20 | 20 | −0 | −0 | −8 | 1 | 4 | −2 | 5 | −0 | −0 | −0 | −0 | −0 |
| Net profit | −50 | −62 | 10 | 8 | −25 | 0 | 14 | −48 | 5 | −12 | −32 | 12 | 6 | −10 |
| Item | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 69 | 383 | 38 | 22 | 12 | 8 | 3 | 24 | 26 | 37 | 20 | 16 | 8 | 10 |
| Equity | 50 | −12 | −3 | 6 | −19 | −18 | −4 | −52 | −47 | −59 | −91 | −79 | −73 | −84 |
| Long-term debt | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 19 | 395 | 40 | 16 | 31 | 26 | 8 | 76 | 73 | 96 | 111 | 96 | 81 | 94 |
| Total debt | 19 | 395 | 40 | 16 | 31 | 26 | 8 | 76 | 73 | 96 | 111 | 96 | 81 | 94 |
EBITDA margin
-29.1%
This company
15.8%
Market median
-284% vs market
20122025
Equity ratio
-854.2%
This company
38.2%
Market median
-2336% vs market
20122025
Return on equity
-1045900.0%
This company
18.4%
Market median
-5684339% vs market
20122025
Net profit margin
-29.3%
This company
8.1%
Market median
-462% vs market
20122025
Asset turnover
3.63×
This company
1.12×
Market median
+224% vs market
20122025
Debt / equity
1.12×
This company
0.62×
Market median
-81% vs market
20122025
- Annual report 2025Filed via Brønnøysundsregistrene · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via Brønnøysundsregistrene · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via Brønnøysundsregistrene · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via Brønnøysundsregistrene · Period 2017-01-01 – 2017-12-31
- Annual report 2016Filed via Brønnøysundsregistrene · Period 2016-01-01 – 2016-12-31
- Annual report 2015Filed via Brønnøysundsregistrene · Period 2015-01-01 – 2015-12-31
- Annual report 2014Filed via Brønnøysundsregistrene · Period 2014-01-01 – 2014-12-31
- Annual report 2013Filed via Brønnøysundsregistrene · Period 2013-01-01 – 2013-12-31
- Annual report 2012Filed via Brønnøysundsregistrene · Period 2012-01-01 – 2012-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
UC Deputy Member | Deputy Member | 2012 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Chairman | 2012 | — | — |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of EPIDEMI AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Unn Christeen Haga Aavitsland | Deputy Member | 0 companies |
| Preben Aavitsland | Chairman | 0 companies |